ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,079,232 | -17.3% | 98,560 | 0.0% | 0.34% | -5.9% |
| Q2 2023 | $1,304,934 | -2.7% | 98,560 | 0.0% | 0.36% | -11.2% |
| Q1 2023 | $1,341,402 | -30.3% | 98,560 | 0.0% | 0.40% | -25.8% |
| Q4 2022 | $1,924,877 | +3.5% | 98,560 | +1.0% | 0.54% | +8.4% |
| Q3 2022 | $1,859,000 | -14.3% | 97,560 | -7.3% | 0.50% | -15.4% |
| Q2 2022 | $2,169,000 | -24.5% | 105,298 | +17.9% | 0.59% | -21.1% |
| Q1 2022 | $2,874,000 | +14.1% | 89,298 | +65.1% | 0.75% | +18.3% |
| Q4 2021 | $2,518,000 | +12.3% | 54,090 | -34.9% | 0.63% | +6.4% |
| Q3 2021 | $2,243,000 | – | 83,061 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |